Hepatic Perfusion: Surgical and Catheter

[1]  D. Bartlett,et al.  Hepatic artery infusion of melphalan in patients with liver metastases from ocular melanoma , 2018, Journal of surgical oncology.

[2]  B. Stedman,et al.  Percutaneous hepatic perfusion with melphalan in uveal melanoma: A safe and effective treatment modality in an orphan disease , 2017, Journal of surgical oncology.

[3]  F. Wacker,et al.  Percutaneous Isolated Hepatic Perfusion as a Treatment for Isolated Hepatic Metastases of Uveal Melanoma: Patient Outcome and Safety in a Multi-centre Study , 2017, CardioVascular and Interventional Radiology.

[4]  William H. Bisson,et al.  Colorectal Cancer Liver Metastasis: Evolving Paradigms and Future Directions , 2017, Cellular and molecular gastroenterology and hepatology.

[5]  C. Nutting,et al.  Results of a Randomized Controlled Multicenter Phase III Trial of Percutaneous Hepatic Perfusion Compared with Best Available Care for Patients with Melanoma Liver Metastases , 2016, Annals of Surgical Oncology.

[6]  S. Zangos,et al.  Chemosaturation with Percutaneous Hepatic Perfusions of Melphalan for Hepatic Metastases: Experience from Two European Centers , 2014, Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren.

[7]  Junsung Choi,et al.  Chemosaturation with percutaneous hepatic perfusion for unresectable metastatic melanoma or sarcoma to the liver: A single institution experience , 2014, Journal of surgical oncology.

[8]  Timothy P. Sheets,et al.  Evaluation of Delcath Systems’ Generation 2 (GEN 2) Melphalan Hemofiltration System in a Porcine Model of Percutaneous Hepatic Perfusion , 2014, CardioVascular and Interventional Radiology.

[9]  Sanjay Gupta.  Intra-Arterial Liver-Directed Therapies for Neuroendocrine Hepatic Metastases , 2013, Seminars in Interventional Radiology.

[10]  C. Sadow,et al.  Hepatic Arterial Chemoembolization Using Drug-Eluting Beads in Gastrointestinal Neuroendocrine Tumor Metastatic to the Liver , 2011, CardioVascular and Interventional Radiology.

[11]  T. Chua,et al.  Progression and survival results after radical hepatic metastasectomy of indolent advanced neuroendocrine neoplasms (NENs) supports an aggressive surgical approach. , 2011, Surgery.

[12]  R. Tollenaar,et al.  Management of isolated nonresectable liver metastases in colorectal cancer patients: a case-control study of isolated hepatic perfusion with melphalan versus systemic chemotherapy. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[13]  V. Servois,et al.  Surgical management of liver metastases from uveal melanoma: 16 years' experience at the Institut Curie. , 2009, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[14]  S. Steinberg,et al.  Analysis of Factors Associated with Outcome in Patients Undergoing Isolated Hepatic Perfusion for Unresectable Liver Metastases from Colorectal Center , 2009, Annals of Surgical Oncology.

[15]  H. Zeh,et al.  A Phase I Study of Hyperthermic Isolated Hepatic Perfusion with Oxaliplatin in the Treatment of Unresectable Liver Metastases from Colorectal Cancer , 2009, Annals of Surgical Oncology.

[16]  R. Tollenaar,et al.  Isolated Hepatic Perfusion with 200 mg Melphalan for Advanced Noncolorectal Liver Metastases , 2008, Annals of Surgical Oncology.

[17]  E. Berber,et al.  Radiofrequency Thermal Ablation of Metastatic Neuroendocrine Tumors in the Liver , 2007, Current treatment options in oncology.

[18]  T. Pilgram,et al.  Long-term outcome after chemoembolization and embolization of hepatic metastatic lesions from neuroendocrine tumors. , 2007, AJR. American journal of roentgenology.

[19]  T. Nicol,et al.  Complete hepatic resection of metastases from leiohyosarcoma prolongs survival , 1998, Journal of Gastrointestinal Surgery.

[20]  T. Pawlik,et al.  Hepatic Resection for Metastatic Melanoma: Distinct Patterns of Recurrence and Prognosis for Ocular Versus Cutaneous Disease , 2006, Annals of Surgical Oncology.

[21]  S. Libutti,et al.  Phase I study of hepatic arterial melphalan infusion and hepatic venous hemofiltration using percutaneously placed catheters in patients with unresectable hepatic malignancies. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  L. Kodjikian,et al.  Treatment of Liver Metastases From Uveal Melanoma , 2005, Annals of Surgical Oncology.

[23]  S. Libutti,et al.  Isolated Hepatic Perfusion for the Treatment of Patients With Colorectal Cancer Liver Metastases After Irinotecan-Based Therapy , 2005, Annals of Surgical Oncology.

[24]  K. Link,et al.  Rationale and indications for perfusion in liver tumors: Current data , 1987, World Journal of Surgery.

[25]  S. Libutti,et al.  Isolated hepatic perfusion for the treatment of patients with advanced liver metastases from pancreatic and gastrointestinal neuroendocrine neoplasms. , 2004, Surgery.

[26]  R. Tollenaar,et al.  Isolated hepatic perfusion with high-dose melphalan for the treatment of uveal melanoma metastases confined to the liver , 2004, Melanoma research.

[27]  S. Steinberg,et al.  Hyperthermic isolated hepatic perfusion using melphalan for patients with ocular melanoma metastatic to liver. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[28]  P. Kuppen,et al.  Isolated hepatic perfusion with high‐dose melphalan for the treatment of colorectal metastasis confined to the liver , 2003, The British journal of surgery.

[29]  T. Kivelä,et al.  Very long-term prognosis of patients with malignant uveal melanoma. , 2003, Investigative ophthalmology & visual science.

[30]  I. Rennie,et al.  Metastasis-free survival following treatment for uveal melanoma with either stereotactic radiosurgery or enucleation. , 2003, Acta ophthalmologica Scandinavica.

[31]  A. Bedikian,et al.  Phase II evaluation of temozolomide in metastatic choroidal melanoma , 2003, Melanoma research.

[32]  Arun D. Singh,et al.  Survival rates with uveal melanoma in the United States: 1973-1997. , 2003, Ophthalmology.

[33]  A. Tarkkanen,et al.  Chemoimmunotherapy with bleomycin, vincristine, lomustine, dacarbazine (BOLD), and human leukocyte interferon for metastatic uveal melanoma , 2002, Cancer.

[34]  S. Libutti,et al.  Hepatic vascular isolation and perfusion for patients with progressive unresectable liver metastases from colorectal carcinoma refractory to previous systemic and regional chemotherapy , 2002, Cancer.

[35]  S. Libutti,et al.  A phase I-II study of isolated hepatic perfusion using melphalan with or without tumor necrosis factor for patients with ocular melanoma metastatic to liver. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[36]  L. Frediani,et al.  Result of liver resection as treatment for metastases from noncolorectal cancer , 2000, Journal of surgical oncology.

[37]  D. Canes,et al.  Hepatic neuroendocrine metastases: does intervention alter outcomes? , 2000, Journal of the American College of Surgeons.

[38]  T. Scherstén,et al.  Isolated hepatic perfusion with extracorporeal oxygenation using hyperthermia, tumour necrosis factor alpha and melphalan. , 1999, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[39]  D. Fraker,et al.  Isolated hepatic perfusion with tumor necrosis factor and melphalan for unresectable cancers confined to the liver. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[40]  C. V. D. van de Velde,et al.  Phase I/II studies of isolated hepatic perfusion with mitomycin C or melphalan in patients with colorectal cancer hepatic metastases. , 1998, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[41]  D. Albert.  REVIEWERS FOR THE PAST YEAR , 1996 .

[42]  E. Borden,et al.  Metastatic ocular and cutaneous melanoma: a comparison of patient characteristics and prognosis. , 1996, Archives of ophthalmology.

[43]  S. Seregard,et al.  Prognostic indicators following enucleation for posterior uveal melanoma. A multivariate analysis of long-term survival with minimized loss to follow-up. , 2009, Acta ophthalmologica Scandinavica.

[44]  R. Benjamin,et al.  Treatment of uveal melanoma metastatic to the liver. A review of the M. D. Anderson cancer center experience and prognostic factors , 1995 .

[45]  K. Batts,et al.  Hepatic resection for metastatic neuroendocrine carcinomas. , 1995, American journal of surgery.

[46]  T. Ravikumar,et al.  Percutaneous hepatic vein isolation and high-dose hepatic arterial infusion chemotherapy for unresectable liver tumors. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[47]  A. Bengtsson,et al.  Isolated hyperthermic liver perfusion with chemotherapy for liver malignancy. , 1994, Surgical oncology.

[48]  N. Renard,et al.  High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[49]  S. Wallace,et al.  The prevalence and location of metastases from ocular melanoma: imaging study in 110 patients. , 1991, AJR. American journal of roentgenology.

[50]  E. Quebbeman,et al.  Tumoricidal effects and patient survival after hyperthermic liver perfusion. , 1986, Archives of surgery.

[51]  D. Alberts,et al.  A clinical and pharmacokinetic study of isolated limb perfusion with heat and melphalan for melanoma , 1985, Cancer.

[52]  J. Tonn,et al.  First experimental and clinical results of isolated liver perfusion with cytotoxics in metastases from colorectal primary. , 1983, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[53]  Stehlin Js,et al.  Hyperthermic perfusion with chemotherapy for cancers of the extremities. , 1969 .

[54]  Ausman Rk.  Development of a technic for isolated perfusion of the liver. , 1961 .

[55]  R. F. Ryan,et al.  Chemotherapy of Cancer: Regional Perfusion Utilizing an Extracorporeal Circuit , 1958, Annals of surgery.

[56]  C. Breedis,et al.  The blood supply of neoplasms in the liver. , 1954, The American journal of pathology.